News
4h
News-Medical.Net on MSNPilocarpine eye drops improve outcomes after Kahook Dual Blade goniotomy surgeryUsing pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...
In CRVO, the buildup occurs in the eye’s ... genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.
This week Bobbi Conner talks with Dr. Jeffrey Blice about the symptoms, causes and diagnosis of eye floaters. Dr. Blice is a ...
The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...
5d
News Medical on MSNGolden eyes: How gold nanoparticles may one day help to restore people’s visionA team of Brown University researchers has identified a promising new approach that may one day help to restore vision in ...
Explore expert advice on eye care, including tips on preventing eye strain, maintaining healthy vision, and selecting the ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...
Adults with dry eye disease and migraine who were treated with eye drops for ocular lubrication experienced significant reductions in migraine severity, according to a study published in Optometry and ...
The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...
more than 10 million people are affected by the problem of glaucoma and this apparently has no cure. However, glaucoma can be treated and prevented by early diagnosis and regular eye check-ups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results